Knobbe Martens partner Andrea Cheek and associate Ari Feinstein authored “Patent Venue, and How It Works in Abbreviated New Drug Application Litigation,” published in Intellectual Property & Technology Law Journal.
In the article, Cheek and Feinstein survey key issues relating to patent venue, including the meaning of the statutory phrases “resides,” “has committed acts of infringement,” and has “a regular and established place of business.”
The authors also address the burden of proof on patent venue, the interplay between venue and protective ANDA suits, and patent venue issues specific to foreign corporations.
Read the full article here.
